| Literature DB >> 28891101 |
Jyotika D Prasad1,2,3, Annabelle Mahar4, Jane Bleasel5,6, Samantha J Ellis7, Daniel C Chambers8,9, Fiona Lake10,11, Peter M A Hopkins8,9, Tamera J Corte12,13, Heather Allan14, Ian N Glaspole1,3.
Abstract
Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).Entities:
Keywords: clinical respiratory medicine; interstitial lung disease; multidisciplinary meeting; pulmonary fibrosis; rare lung diseases
Mesh:
Year: 2017 PMID: 28891101 DOI: 10.1111/resp.13163
Source DB: PubMed Journal: Respirology ISSN: 1323-7799 Impact factor: 6.424